Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Levy Richard S
Relationship:  
City:   Wilmington
State:   DE
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   67,748    

Indirect Shares

   0      
Direct Value   $3,274,842    

Indirect Value

   $0      
Total Shares   67,748      
Total Value   $3,274,842      


Incyte Corp $898,094 Madrigal Pharmaceuticals Inc $2,113,665 Protara Therapeutics, Inc $93,000 Kodiak Sciences Inc. $3,610 Kiniksa Pharmaceuticals, Ltd. $166,474 Incyte Corp $898,094 Madrigal Pharmaceuticals Inc $2,113,665 Protara Therapeutics, Inc $93,000 Kodiak Sciences Inc. $3,610 Kiniksa Pharmaceuticals, Ltd. $166,474
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   0.0   
     Percentage Gain/Loss :
   195.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY EVP, Chief Drug Dev Of... 2016-01-06 16,926 2010-03-15 0    Premium*  
            Madrigal Pharmaceuticals Inc MDGL 2024-04-01 10,298 2017-08-21 0    Premium*  
            Protara Therapeutics, Inc TARA Director 2020-01-10 31,000 2020-01-10 0    Premium*  
            Kodiak Sciences Inc. KOD Director 2020-03-20 1,000 2020-03-20 0    Premium*  
            Kiniksa Pharmaceuticals, Ltd. KNSA 2024-05-03 8,524 2023-06-29 0    Premium*  
* Premium Members only  

Records found :    81         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2010-03-15 4 S $12.94 $258,800 D/D (20,000) 0 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2010-03-15 4 OE $4.19 $83,800 D/D 20,000 20,000 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2011-01-18 4 AS $15.77 $636,847 D/D (40,310) 0 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2011-01-18 4 OE $4.19 $270,139 D/D 40,310 40,310 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2012-04-27 4 OE $8.19 $262,948 D/D 30,000 30,000 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2012-04-27 4 AS $22.95 $688,500 D/D (30,000) 0 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2013-02-15 4 S $22.48 $2,212,931 D/D (98,440) 0 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2013-02-15 4 OE $5.46 $673,176 D/D 98,440 98,440 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2013-05-13 4 S $22.30 $1,242,088 D/D (55,699) 4,301 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2013-05-13 4 OE $7.09 $425,400 D/D 60,000 60,000 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2013-09-06 4 S $35.28 $882,000 D/D (25,000) 0 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2013-09-06 4 OE $11.98 $299,500 D/D 25,000 25,000 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-02-13 4 S $66.38 $12,699,091 D/D (191,309) 4,301 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-02-13 4 OE $3.11 $1,595,213 D/D 191,309 195,610 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-02-14 4 OE $9.41 $433,346 D/D 39,787 44,088 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-02-14 4 S $66.13 $2,631,114 D/D (39,787) 4,301 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-05-16 4 AS $50.68 $405,440 D/D (8,000) 4,301 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-05-16 4 OE $14.72 $117,760 D/D 8,000 12,301 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-06-16 4 AS $53.88 $431,040 D/D (8,000) 4,301 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-06-16 4 OE $14.72 $117,760 D/D 8,000 12,301 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-07-16 4 OE $14.72 $117,760 D/D 8,000 12,301 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-07-16 4 AS $48.15 $385,200 D/D (8,000) 4,301 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-08-18 4 AS $51.97 $415,760 D/D (8,000) 4,301 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-08-18 4 OE $14.72 $117,760 D/D 8,000 12,301 0 -
INCY Incyte Corp EVP, Chief Drug Dev&Medical Of   •       –      –    2014-09-16 4 AS $47.58 $380,640 D/D (8,000) 4,301 0 -
  81  Records found
  1  2   3   4      
  Page 1 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us